Recent News
The Brett Lindenbach Virology Fund will support an endowed lecture and training that honors Brett’s contributions to virology at Yale and beyond. In order for the fund to be sustainable, our goal is to raise $100,000 by October 1st, 2024. We hope you will join us to create this lasting legacy to celebrate Brett Lindenbach.
- March 01, 2024Source: YaleNews
Yale scientists have discovered a family of immune proteins that could affect the way our bodies fight infection.
- December 20, 2023
Brett Lindenbach, PhD, associate professor of microbial pathogenesis and of comparative medicine at Yale School of Medicine, died on December 16, 2023. He was 55.
- September 21, 2023Source: HHMI
Scientists have found that cells that line human lungs and other tissues express a protein that can halt SARS-CoV-2 replication before the virus spreads to nearby cells. Their discovery could one day point to new therapeutic strategies to treat or prevent COVID-19, particularly for individuals who are more vulnerable to severe infection.
- September 06, 2023Source: JAMA
The most common vector-borne disease in the US, Lyme disease, is on the rise.
- August 25, 2023
The American College of Physicians (ACP) Internal Medicine Award is conferred each year to a graduating medical student from Yale School of Medicine (YSM) who plans to enter an internal medicine residency in Connecticut. YSM faculty members Barry Wu, MD, FACP, professor of medicine (geriatrics) and Nancy Angoff, MD, MPH, MEd, professor emerita of medicine (general medicine) established the award in 1999, in collaboration with faculty from the University of Connecticut School of Medicine.
- August 24, 2023Source: Newsbreak
As more tick and mosquito-borne illness cases crop up in the U.S., researchers at Yale School of Medicine are looking to make a vaccine that will target those diseases. Most vaccines available to us usually target a pathogen or microbe, but there are many infectious diseases that are transmitted by vectors.
- July 25, 2023Source: Stamford Advocate
A group of Yale researchers is working on a new kind of vaccine they believe could change the world: instead of acting against a pathogen, the vaccine would reduce the risk of transmission for mosquito-and-tick-borne illnesses by targeting the insects themselves.
- July 25, 2023
Assistant Professor Hualiang Pi arrives in Fall, 2023.
- July 12, 2023Source: YaleNews
When activated, a protein found in cells that line the body’s tissues can inhibit viral spread — offering the potential for a new defense against COVID-19.